| The immunological synapse balances T cell receptor signaling and degradation KH Lee, AR Dinner, C Tu, G Campi, S Raychaudhuri, R Varma, TN Sims, ... science 302 (5648), 1218-1222, 2003 | 664 | 2003 |
| Long-term T cell memory requires the surface expression of self-peptide/major histocompatibility complex molecules MA Markiewicz, C Girao, JT Opferman, J Sun, Q Hu, AA Agulnik, ... Proceedings of the National Academy of Sciences 95 (6), 3065-3070, 1998 | 229 | 1998 |
| Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression S Achilefu, S Bloch, MA Markiewicz, T Zhong, Y Ye, RB Dorshow, ... Proceedings of the National Academy of Sciences 102 (22), 7976-7981, 2005 | 176 | 2005 |
| The balance between T cell receptor signaling and degradation at the center of the immunological synapse is determined by antigen quality S Čemerski, J Das, E Giurisato, MA Markiewicz, PM Allen, ... Immunity 29 (3), 414-422, 2008 | 167 | 2008 |
| Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation MA Markiewicz, LN Carayannopoulos, OV Naidenko, K Matsui, ... The Journal of Immunology 175 (5), 2825-2833, 2005 | 136 | 2005 |
| The stimulatory potency of T cell antigens is influenced by the formation of the immunological synapse S Čemerski, J Das, J Locasale, P Arnold, E Giurisato, MA Markiewicz, ... Immunity 26 (3), 345-355, 2007 | 118 | 2007 |
| Spontaneous rejection of poorly immunogenic P1. HTR tumors by Stat6-deficient mice AK Kacha, F Fallarino, MA Markiewicz, TF Gajewski The Journal of Immunology 165 (11), 6024-6028, 2000 | 118 | 2000 |
| Depletion of normal B cells with rituximab as an adjunct to IL-2 therapy for renal cell carcinoma and melanoma M Aklilu, WM Stadler, M Markiewicz, NJ Vogelzang, M Mahowald, ... Annals of Oncology 15 (7), 1109-1114, 2004 | 76 | 2004 |
| Antigen-specific blockade of T cells in vivo using dimeric MHC peptide SM O’Herrin, JE Slansky, Q Tang, MA Markiewicz, TF Gajewski, ... The Journal of Immunology 167 (5), 2555-2560, 2001 | 74 | 2001 |
| Epitope spreading upon P815 tumor rejection triggered by vaccination with the single class I MHC-restricted peptide P1A MA Markiewicz, F Fallarino, A Ashikari, TF Gajewski International immunology 13 (5), 625-632, 2001 | 66 | 2001 |
| CD4+ T cell matters in tumor immunity MP Velders, MA Markiewicz, GL Eiben, W Martin Kast International reviews of immunology 22 (2), 113-140, 2003 | 57 | 2003 |
| The immune system as anti-tumor sentinel: molecular requirements for an anti-tumor immune response. MA Markiewicz, TF Gajewski Critical Reviews in Oncogenesis 10 (3), 247-260, 1999 | 56 | 1999 |
| RAE1ε ligand expressed on pancreatic islets recruits NKG2D receptor-expressing cytotoxic T cells independent of T cell receptor recognition MA Markiewicz, EL Wise, ZS Buchwald, AK Pinto, B Zafirova, B Polic, ... Immunity 36 (1), 132-141, 2012 | 55 | 2012 |
| Progress in the development of immunotherapy of cancer using ex vivo-generated dendritic cells expressing multiple tumor antigen epitopes MA Markiewicz, WM Kast Cancer investigation 22 (3), 417-434, 2004 | 54 | 2004 |
| ICAM-1 contributes to but is not essential for tumor antigen cross-priming and CD8+ T cell-mediated tumor rejection in vivo C Blank, I Brown, AK Kacha, MA Markiewicz, TF Gajewski The Journal of Immunology 174 (6), 3416-3420, 2005 | 45 | 2005 |
| IL-12 enhances CTL synapse formation and induces self-reactivity MA Markiewicz, EL Wise, ZS Buchwald, EE Cheney, TH Hansen, A Suri, ... The Journal of Immunology 182 (3), 1351-1361, 2009 | 42 | 2009 |
| Progesterone receptor attenuates STAT1-mediated IFN signaling in breast cancer ML Goodman, GM Trinca, KR Walter, EK Papachristou, CS D’Santos, T Li, ... The Journal of Immunology 202 (10), 3076-3086, 2019 | 41 | 2019 |
| Death of peripheral CD8+ T cells in the absence of MHC class I is Fas‐dependent and not blocked by Bcl‐xL MA Markiewicz, I Brown, TF Gajewski European journal of immunology 33 (10), 2917-2926, 2003 | 40 | 2003 |
| Coexpression of FOXP3 and a Helios isoform enhances the effectiveness of human engineered regulatory T cells A Seng, KL Krausz, D Pei, DC Koestler, RT Fischer, TM Yankee, ... Blood advances 4 (7), 1325-1339, 2020 | 31 | 2020 |
| Immunotherapy for urological malignancies KG Krejci, MA Markiewicz, ED Kwon The Journal of urology 171 (2), 870-876, 2004 | 30 | 2004 |
